scholarly article | Q13442814 |
P50 | author | Kwang Seok Ahn | Q60962653 |
P2093 | author name string | Bruce E Blough | |
Jae-Young Um | |||
Arunachalam Chinnathambi | |||
Sulaiman Ali Alharbi | |||
Ojas A Namjoshi | |||
Acharan S Narula | |||
Sun Tae Hwang | |||
P2860 | cites work | Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. | Q39717015 |
Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. | Q39952649 | ||
Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. | Q40162826 | ||
Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model. | Q40230015 | ||
Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. | Q40555412 | ||
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo | Q41288594 | ||
Induction of mitotic arrest and apoptosis in human prostate cancer pc-3 cells by evodiamine | Q44514353 | ||
Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells | Q46507040 | ||
Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis | Q47613918 | ||
Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway. | Q50529164 | ||
Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma | Q51140975 | ||
Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. | Q52657235 | ||
Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion | Q52672847 | ||
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer | Q52682976 | ||
Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways | Q52857839 | ||
Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells | Q52861786 | ||
Rising prostate cancer rates in South Korea | Q53595889 | ||
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015. | Q55283691 | ||
Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo. | Q55286443 | ||
Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway | Q58712167 | ||
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies | Q58742654 | ||
Prognostic Significance of Plasma Scatter Factor/Hepatocyte Growth Factor Levels in Patients with Metastatic Hormone- Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 150005/9480 | Q60156301 | ||
Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model | Q61804238 | ||
Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer's Disease | Q64057778 | ||
Prediction of Cancer Incidence and Mortality in Korea, 2019 | Q64079016 | ||
Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade | Q64109917 | ||
Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade | Q64251032 | ||
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer | Q73638272 | ||
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma | Q90419417 | ||
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway | Q91069762 | ||
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator | Q92545358 | ||
CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cells | Q92600212 | ||
Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways | Q92988098 | ||
Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells | Q93119350 | ||
Prostate cancer and the met hepatocyte growth factor receptor | Q28278555 | ||
New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo | Q30576918 | ||
Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer | Q33566628 | ||
BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro | Q33591926 | ||
Management of complications of prostate cancer treatment | Q33978360 | ||
Activation of c-MET induces a stem-like phenotype in human prostate cancer | Q34081431 | ||
Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells. | Q34283730 | ||
Anti-proliferative effects of evodiamine in human lung cancer cells | Q34305470 | ||
Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo | Q34634316 | ||
Targeting PPARγSignaling Cascade for the Prevention and Treatment of Prostate Cancer | Q34646050 | ||
Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells | Q34991240 | ||
Natural bioactives in cancer treatment and prevention | Q35337444 | ||
Castration-resistant prostate cancer: systemic therapy in 2012 | Q35865011 | ||
Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells. | Q36077939 | ||
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy | Q37071019 | ||
From AR to c-Met: androgen deprivation leads to a signaling pathway switch in prostate cancer cells | Q37313321 | ||
Morin (3,5,7,2',4'-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis | Q37338875 | ||
Natural bioactives and phytochemicals serve in cancer treatment and prevention. | Q37433047 | ||
Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. | Q38030337 | ||
Do STAT3 inhibitors have potential in the future for cancer therapy? | Q38656557 | ||
Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis | Q38736918 | ||
Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo | Q38771177 | ||
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells | Q38791918 | ||
Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling | Q38857711 | ||
In Vitro Assessment of the Anticancer Potential of Evodiamine in Human Oral Cancer Cell Lines | Q38883365 | ||
β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. | Q39139874 | ||
Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer | Q39143805 | ||
Prostate cancer stem‐like cells/cancer‐initiating cells have an autocrine system of hepatocyte growth factor | Q39210179 | ||
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. | Q39393075 | ||
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. | Q39500189 | ||
Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. | Q39669022 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P921 | main subject | cell growth | Q189159 |
P577 | publication date | 2020-03-13 | |
P1433 | published in | Molecules | Q151332 |
P1476 | title | Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells | |
P478 | volume | 25 |
Search more.